PROSTATE-SPECIFIC ANTIGEN (PSA) - ANVISA Registration 80680420094

Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80680420094 and manufactured by BIO BRASIL BIOTECNOLOGIA LTDA. The registration is held by BIO BRASIL BIOTECNOLOGIA LTDA with validity until Jan 08, 2034.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.